language_icon
EN
HI

Sanofi India Share price

SANOFI

3330.6

60.00 (-1.77%)
NSE
BSE
Last updated on 8 May, 2026 | 15:46 IST
Today's High

3400.80

Today's Low

3323.00

52 Week Low

3160.00

52 Week High

6410.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Sanofi India Chart

Sanofi India Share Key Metrics

Volume
35014.00
Market Cap
7670.58 CR
LTQ@LTP
11@3330.60
ATP
3345.88
Var Margin
12.5 %
Circuit Range
2712.5-4068.7
Delivery %
58.79 %
Value
11.72 CR
ASM/GSM
No
Market Lot
1

Summary

Sanofi India share price stands at ₹3330.6 at 8 May, 2026 | 15:46. The stock Sanofi India intraday movement has stayed between ₹3323.00 and ₹3400.80, while on a 52-week basis it has fluctuated from ₹3160.00 to ₹6410.00.
In terms of trading activity, Sanofi India has recorded a volume of 35014 shares. The Sanofi India has a market cap of ₹23030622. The stock’s Average Traded Price (ATP) stands at ₹334588, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 11, 333060.
The Sanofi India operates within a circuit range of ₹2712.5-4068.7 – ₹2712.5-4068.7, with a Value of ₹11.72 CR. The Delivery Percentage for the day is 58.79%. Additionally, Sanofi India currently falls under the No framework, and trades with a market lot size of 1.

Sanofi India Fundamentals

View More
P/E Ratio

18.54

P/B Ratio

9.69

Div. Yield

3.7

Sector P/E

68.46

Sector P/B

3.55

Sec. Div. Yield

0.57

Sanofi India Resistance and Support

Pivot 3404.57

Resistance

First Resistance

3424.04

Second Resistance

3457.47

Third Resistance

3476.94

Support

First Support

3371.14

Second Support

3351.67

Third Support

3318.24

Sanofi India Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

60.4%

Mutual Fund

9.26%

Insurance

11.86%

Foreign Institutional Investors

5.65%

Domestic Institutional Investors

0%

Retail

12.83%

Others

0%

Total Promoters
MAR '26
60.4%

Sanofi India Corporate Actions

DateAgenda
2026-04-28Quarterly Results
2026-02-25Quarterly Results & Interim Dividend
2025-10-29Quarterly Results & Interim Dividend
2025-07-31Quarterly Results
2025-05-14Quarterly Results
2025-02-27Audited Results & Final Dividend

Sanofi India News

Sanofi India Limited

Sanofi India Limited appointed Mr. Rahul Bhatnagar as the Chairman of its Board of Directors, effective April 30, 2026. He brings extensive experience in finance, strategy, and governance.
Apr 30 2026 16:04:00

Sanofi India Limited

Sanofi India's 70th Annual General Meeting concluded with the approval of a total dividend of Rs.123 per share for the financial year ended December 31, 2025. The meeting also approved the appointment of Rahul Bhatnagar as Chairman and Sudipta Chakraborty as Whole-time Director, effective April 30, 2026, along with ratification of material related party transactions.
Apr 29 2026 20:04:00

Sanofi India Limited

Sanofi India shareholders approved the appointment of Ms. Sudipta Chakraborty as Whole-time Director. The company also secured approval for two material related party transactions and declared a final dividend of Rs.48 per equity share for FY25.
Apr 29 2026 20:04:00

Sanofi India Limited

Sanofi India's board appointed Rahul Bhatnagar as Chairman, effective April 30, 2026. The board also noted the tenure completion of Independent Directors Aditya Narayan and Usha Thorat on April 29, 2026.
Apr 28 2026 20:04:00

Sanofi India Limited

Sanofi India's board appointed Rahul Bhatnagar as Chairman, effective April 30, 2026. The board also noted the tenure completion of Independent Directors Aditya Narayan and Usha Thorat on April 29, 2026.
Apr 28 2026 19:04:00

Sanofi India Limited

Sanofi India's board approved Q4 FY26 results with revenue of ₹472.3 crore and net profit of ₹102.6 crore. The insulin portfolio showed strong double-digit growth. Additionally, Mr. Rahul Bhatnagar has been appointed as the new Chairman of the Board.
Apr 28 2026 19:04:00

Sanofi India Limited

Sanofi India's board approved Q4 FY26 results with revenue of ₹472.3 crore and net profit of ₹102.6 crore. The insulin portfolio showed strong double-digit growth. Additionally, Mr. Rahul Bhatnagar has been appointed as the new Chairman of the Board.
Apr 28 2026 18:04:00

Sanofi India Limited

Sanofi India's board approved Q4 FY26 results with revenue of ₹472.3 crore and net profit of ₹102.6 crore. The insulin portfolio showed strong double-digit growth. Additionally, Mr. Rahul Bhatnagar has been appointed as the new Chairman of the Board.
Apr 28 2026 18:04:00

Sanofi India Limited

Sanofi India's board approved Q4 FY26 results with revenue of ₹472.3 crore and net profit of ₹102.6 crore. The insulin portfolio showed strong double-digit growth. Additionally, Mr. Rahul Bhatnagar has been appointed as the new Chairman of the Board.
Apr 28 2026 18:04:00

Sanofi India Ltd - 500674 - Board Meeting Outcome for Of The Board Meeting Of The Company

Sanofi India reported Q1 FY26 revenue of ₹472.3 crores, a decrease of 11.88% YoY, and net profit of ₹102.6 crores, down 14.14% YoY. The company's insulin portfolio showed double-digit growth, and Mr. Rahul Bhatnagar was appointed as Chairman of the Board effective April 30, 2026.
Apr 28 2026 18:04:00
Read More

About Sanofi India

NSE : 1442  
BSE : 500674  
ISIN : INE058A01010  

Sanofi India Management

NamePosition
Aditya NarayanChairman
Rahul BhatnagarChairman
View More

Sanofi India FAQs

The Buying Price of Sanofi India share is 3330.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Sanofi India stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sanofi India, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Sanofi India shares is 18.54. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Sanofi India shares is 9.69. Useful to assess the stock's value relative to its book value.

To assess Sanofi India’s valuation compare Sector P/E, P/B which are 68.46 & 3.55 with sector averages, along with growth rates and financial metrics.

The Market Cap of Sanofi India is 7670.58 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Sanofi India share price is 6410.00 & 3160.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Sanofi India belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost